Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1139752

registered interest
date	17/07/2019
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Environment Protection: UK Shared Prosperity Fund
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Environment, Food and Rural Affairs, what discussions he has had with the (a) Chancellor of the Exchequer and (b) Secretary of State for Housing, Communities and Local Government on ensuring the UK Shared Prosperity Fund contributes to the achievement of the goals set out in the 25 Year Environment Plan.
tabling member constituency	Ceredigion
tabling member printed	Ben Lake
uin	278577
answer	answer is ministerial correction date of answer 30/07/2019 answer text <p>The previous Secretary of State had regular discussions on a range of issues with those ministers. Officials are working closely together on the design of the UK Shared Prosperity Fund to ensure it supports a range of Government priorities.</p> answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey question first answered 30/07/2019 09:00:06 answering member 4098 label Biography information for Dr Thérèse Coffey
tabling member	4630 label Biography information for Ben Lake

1139868

registered interest
date	17/07/2019
answering body	Ministry of Defence
answering dept id	11
answering dept short name	Defence
answering dept sort name	Defence
hansard heading	Defence Medical Services: Training
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Defence, what his Department's policy is on participation of military surgeons in overseas training exercises involving animals that have been shot or otherwise injured with offensive weapons for the purpose of that exercise.
tabling member constituency	Ceredigion
tabling member printed	Ben Lake
uin	278578
answer	answer is ministerial correction date of answer 23/07/2019 answer text <p>The Ministry of Defence takes very seriously its obligation to provide the best possible medical treatment for Service personnel wounded on operational service. The quality of care delivered by the Defence Medical Services (DMS) is directly related to the thoroughness with which we prepare our deployed surgical teams for the sorts of serious injuries they will encounter.</p><p>This training is delivered through a range of different courses and exercises, many of which employ complex simulation models such as programmable mannequins. However, simulators are currently unable to replace all trauma training. Even the most sophisticated of them are not technologically advanced enough to respond physiologically to complex surgical procedures. At present, the only means for our surgical teams to get the necessary training in the control of real-time internal haemorrhage from combat injury is through live tissue training (LTT).</p><p>Up to twice a year, members of the DMS attend surgical training exercises in Denmark, during which live but fully anaesthetised pigs are given bullet and blast wounds which are then treated in real-time exercises by surgical teams. The animals are unconscious during the entire exercise, and feel no pain. They are attended at all times by veterinary staff, who may withdraw them at any time for any reason, and the animals are humanely put down at the end of the training procedures without recovering consciousness.</p><p>The DMS have collaborated on a number of research programmes into simulator technology, and constantly monitors the latest developments, especially where they might in future offer an alternative means of delivering this specialised but vital training.</p> answering member constituency Bournemouth East answering member printed Mr Tobias Ellwood question first answered 23/07/2019 13:09:59 answering member 1487 label Biography information for Mr Tobias Ellwood
tabling member	4630 label Biography information for Ben Lake

1139869

registered interest
date	17/07/2019
answering body	Ministry of Defence
answering dept id	11
answering dept short name	Defence
answering dept sort name	Defence
hansard heading	Dstl: Animal Experiments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Defence, how many of the 3,865 animals used in scientific procedures at DSTL Porton Down in 2017 were experimented upon under a multiple generic licence.
tabling member constituency	Ceredigion
tabling member printed	Ben Lake
uin	278579
answer	answer is ministerial correction date of answer 22/07/2019 answer text <p>The Defence Science and Technology Laboratory (Dstl) at Porton Down, Wiltshire, is licensed by the Home Office to conduct the Ministry of Defence's in-house research involving the use of animals.</p><p>In 2017 and 2018, no animals were used in scientific procedures at Dstl Porton Down under a multiple generic licence. Dstl does not hold licences of this type.</p><p>Animals are used in experiments to develop new vaccines, therapies and treatments that save the lives of UK military and can benefit civilians. Chemical and biological weapons are a real and present threat. That is why Dstl continues its vital work in providing better protection against the use of these agents and against conventional threats.</p> answering member constituency Pudsey answering member printed Stuart Andrew grouped question UIN 278580 question first answered 22/07/2019 16:19:42 answering member 4032 label Biography information for Stuart Andrew
tabling member	4630 label Biography information for Ben Lake

1139870

registered interest
date	17/07/2019
answering body	Ministry of Defence
answering dept id	11
answering dept short name	Defence
answering dept sort name	Defence
hansard heading	Dstl: Animal Experiments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Defence, how many of the 1,941 animals used in scientific procedures at DSTL Porton Down in 2018 were experimented upon under a multiple generic licence.
tabling member constituency	Ceredigion
tabling member printed	Ben Lake
uin	278580
answer	answer is ministerial correction date of answer 22/07/2019 answer text <p>The Defence Science and Technology Laboratory (Dstl) at Porton Down, Wiltshire, is licensed by the Home Office to conduct the Ministry of Defence's in-house research involving the use of animals.</p><p>In 2017 and 2018, no animals were used in scientific procedures at Dstl Porton Down under a multiple generic licence. Dstl does not hold licences of this type.</p><p>Animals are used in experiments to develop new vaccines, therapies and treatments that save the lives of UK military and can benefit civilians. Chemical and biological weapons are a real and present threat. That is why Dstl continues its vital work in providing better protection against the use of these agents and against conventional threats.</p> answering member constituency Pudsey answering member printed Stuart Andrew grouped question UIN 278579 question first answered 22/07/2019 16:19:42 answering member 4032 label Biography information for Stuart Andrew
tabling member	4630 label Biography information for Ben Lake

1136243

registered interest
date	02/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes: Imports
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with representatives of suppliers of medical radioisotopes on the feasibility of using air freight to import their products in the event that the UK leaves the EU without a deal.
tabling member constituency	Ceredigion
tabling member printed	Ben Lake
uin	272239
answer	answer is ministerial correction date of answer 10/07/2019 answer text <p>The Government maintains that leaving the European Union with a deal is the best exit outcome and has strongly expressed its opposition to leaving without a deal, in line with the position consistently expressed by Parliament. However, leaving without a deal on 31 October 2019 remains the legal default at the end of the Article 50 extension period if no withdrawal agreement is agreed. Therefore, as a responsible Government, we will continue to prepare to minimise any disruption to the supply of medicines and medical products in a ‘no deal’ scenario.</p><p>The Department continues to work closely with the devolved administrations, industry trade bodies and suppliers, the National Health Service and our other main stakeholders to ensure that we are prepared for leaving the EU without a deal in October.</p><p>On 26 June, we wrote to suppliers of medicines to the United Kingdom from or via the EU or wider European Economic Area (EEA) setting out our continuing multi-layered approach to ensure the continuity of supply of all medicines and medical products in a potential ‘no deal’ exit scenario on 31 October. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>We recognise that some medical radioisotopes have a short shelf life and cannot be stockpiled. Therefore, as part of the Department’s contingency planning ahead of a possible March/April 2019 ‘no deal’ scenario, where medical radioisotope products were imported to the UK from the EU or EEA via road haulage and roll-on, roll-off sea, road and rail routes, we asked suppliers to ensure that they had plans in place to air freight those products to avoid any border delays that may have arisen in a no-deal scenario. We worked extensively with these suppliers to ensure plans were in place and are continuing to do so, to ensure that robust contingency arrangements continue to be in place ahead of a possible ‘no deal’ EU exit on 31 October.</p><p> </p><p>The Department has not had discussions with the Civil Aviation Agency in relation to this issue as they are the Government’s expert arm’s length body for the safety, security and economic regulation of civil aviation in the UK. We are, however, working very closely with the Department for Transport.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 272240 272241 question first answered 10/07/2019 16:43:03 answering member 1585 label Biography information for Stephen Hammond
tabling member	4630 label Biography information for Ben Lake

1136244

registered interest
date	02/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes: Imports
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what representations he has received from the suppliers of medical radioisotopes on the potential risk to the import of those instruments in the event that the UK leaves the EU without an agreement.
tabling member constituency	Ceredigion
tabling member printed	Ben Lake
uin	272240
answer	answer is ministerial correction date of answer 10/07/2019 answer text <p>The Government maintains that leaving the European Union with a deal is the best exit outcome and has strongly expressed its opposition to leaving without a deal, in line with the position consistently expressed by Parliament. However, leaving without a deal on 31 October 2019 remains the legal default at the end of the Article 50 extension period if no withdrawal agreement is agreed. Therefore, as a responsible Government, we will continue to prepare to minimise any disruption to the supply of medicines and medical products in a ‘no deal’ scenario.</p><p>The Department continues to work closely with the devolved administrations, industry trade bodies and suppliers, the National Health Service and our other main stakeholders to ensure that we are prepared for leaving the EU without a deal in October.</p><p>On 26 June, we wrote to suppliers of medicines to the United Kingdom from or via the EU or wider European Economic Area (EEA) setting out our continuing multi-layered approach to ensure the continuity of supply of all medicines and medical products in a potential ‘no deal’ exit scenario on 31 October. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>We recognise that some medical radioisotopes have a short shelf life and cannot be stockpiled. Therefore, as part of the Department’s contingency planning ahead of a possible March/April 2019 ‘no deal’ scenario, where medical radioisotope products were imported to the UK from the EU or EEA via road haulage and roll-on, roll-off sea, road and rail routes, we asked suppliers to ensure that they had plans in place to air freight those products to avoid any border delays that may have arisen in a no-deal scenario. We worked extensively with these suppliers to ensure plans were in place and are continuing to do so, to ensure that robust contingency arrangements continue to be in place ahead of a possible ‘no deal’ EU exit on 31 October.</p><p> </p><p>The Department has not had discussions with the Civil Aviation Agency in relation to this issue as they are the Government’s expert arm’s length body for the safety, security and economic regulation of civil aviation in the UK. We are, however, working very closely with the Department for Transport.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 272239 272241 question first answered 10/07/2019 16:43:03 answering member 1585 label Biography information for Stephen Hammond
tabling member	4630 label Biography information for Ben Lake

1136245

registered interest
date	02/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes: Imports
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with the Civil Aviation Authority on the potential risk to the import of medical radioisotopes in the event that the UK leaves the EU without an agreement.
tabling member constituency	Ceredigion
tabling member printed	Ben Lake
uin	272241
answer	answer is ministerial correction date of answer 10/07/2019 answer text <p>The Government maintains that leaving the European Union with a deal is the best exit outcome and has strongly expressed its opposition to leaving without a deal, in line with the position consistently expressed by Parliament. However, leaving without a deal on 31 October 2019 remains the legal default at the end of the Article 50 extension period if no withdrawal agreement is agreed. Therefore, as a responsible Government, we will continue to prepare to minimise any disruption to the supply of medicines and medical products in a ‘no deal’ scenario.</p><p>The Department continues to work closely with the devolved administrations, industry trade bodies and suppliers, the National Health Service and our other main stakeholders to ensure that we are prepared for leaving the EU without a deal in October.</p><p>On 26 June, we wrote to suppliers of medicines to the United Kingdom from or via the EU or wider European Economic Area (EEA) setting out our continuing multi-layered approach to ensure the continuity of supply of all medicines and medical products in a potential ‘no deal’ exit scenario on 31 October. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>We recognise that some medical radioisotopes have a short shelf life and cannot be stockpiled. Therefore, as part of the Department’s contingency planning ahead of a possible March/April 2019 ‘no deal’ scenario, where medical radioisotope products were imported to the UK from the EU or EEA via road haulage and roll-on, roll-off sea, road and rail routes, we asked suppliers to ensure that they had plans in place to air freight those products to avoid any border delays that may have arisen in a no-deal scenario. We worked extensively with these suppliers to ensure plans were in place and are continuing to do so, to ensure that robust contingency arrangements continue to be in place ahead of a possible ‘no deal’ EU exit on 31 October.</p><p> </p><p>The Department has not had discussions with the Civil Aviation Agency in relation to this issue as they are the Government’s expert arm’s length body for the safety, security and economic regulation of civil aviation in the UK. We are, however, working very closely with the Department for Transport.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 272239 272240 question first answered 10/07/2019 16:43:03 answering member 1585 label Biography information for Stephen Hammond
tabling member	4630 label Biography information for Ben Lake

1136246

registered interest
date	02/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with his EU counterparts on the supply of medicines from other EU member states in the event that the UK leaves the EU without an agreement.
tabling member constituency	Ceredigion
tabling member printed	Ben Lake
uin	272242
answer	answer is ministerial correction date of answer 10/07/2019 answer text <p>The Government maintains that leaving the European Union with a deal is the best exit outcome and has strongly expressed its opposition to leaving without a deal, in line with the position consistently expressed by Parliament. However, leaving without a deal on 31 October 2019 remains the legal default at the end of the Article 50 extension period if no withdrawal agreement is agreed. Therefore, as a responsible Government, we will continue to prepare to minimise any disruption to the supply of medicines and medical products in a ‘no deal’ scenario.</p><p> </p><p>The Department continues to work closely with the devolved administrations, relevant EU member states, industry trade bodies and suppliers, the National Health Service and our other main stakeholders to ensure that we are prepared for leaving the EU without a deal in October.</p><p>On 26 June, we wrote to suppliers of medicines to the United Kingdom from or via the EU or European Economic Area setting out our continuing multi-layered approach to ensure the continuity of supply of all medicines and medical products in a potential ‘no deal’ scenario on 31 October. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>We recognise that suppliers may incur additional storage costs for stockpiling medicines or switching to air freight We have been working closely with industry to minimise costs and support medicine suppliers taking part in the contingency programme.</p><p>The provision for additional warehouse space procured for a possible 29 March ‘no deal’ exit remains available for the 31 October deadline. The Department expects to spend around £11 million over the life of these contracts.</p><p> </p><p> </p><p> </p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 272243 272244 272245 272246 question first answered 10/07/2019 16:43:54 answering member 1585 label Biography information for Stephen Hammond
tabling member	4630 label Biography information for Ben Lake

1136247

registered interest
date	02/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect on the ability of suppliers of medicines based in the EU to maintain medical supplies to the UK in the event that the UK leaves the EU.
tabling member constituency	Ceredigion
tabling member printed	Ben Lake
uin	272243
answer	answer is ministerial correction date of answer 10/07/2019 answer text <p>The Government maintains that leaving the European Union with a deal is the best exit outcome and has strongly expressed its opposition to leaving without a deal, in line with the position consistently expressed by Parliament. However, leaving without a deal on 31 October 2019 remains the legal default at the end of the Article 50 extension period if no withdrawal agreement is agreed. Therefore, as a responsible Government, we will continue to prepare to minimise any disruption to the supply of medicines and medical products in a ‘no deal’ scenario.</p><p> </p><p>The Department continues to work closely with the devolved administrations, relevant EU member states, industry trade bodies and suppliers, the National Health Service and our other main stakeholders to ensure that we are prepared for leaving the EU without a deal in October.</p><p>On 26 June, we wrote to suppliers of medicines to the United Kingdom from or via the EU or European Economic Area setting out our continuing multi-layered approach to ensure the continuity of supply of all medicines and medical products in a potential ‘no deal’ scenario on 31 October. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>We recognise that suppliers may incur additional storage costs for stockpiling medicines or switching to air freight We have been working closely with industry to minimise costs and support medicine suppliers taking part in the contingency programme.</p><p>The provision for additional warehouse space procured for a possible 29 March ‘no deal’ exit remains available for the 31 October deadline. The Department expects to spend around £11 million over the life of these contracts.</p><p> </p><p> </p><p> </p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 272242 272244 272245 272246 question first answered 10/07/2019 16:43:55 answering member 1585 label Biography information for Stephen Hammond
tabling member	4630 label Biography information for Ben Lake

1136248

registered interest
date	02/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with his European Union counterparts on the maintenance of supply of medicines from the EU to the UK in the event that the UK leaves the EU without a deal.
tabling member constituency	Ceredigion
tabling member printed	Ben Lake
uin	272244
answer	answer is ministerial correction date of answer 10/07/2019 answer text <p>The Government maintains that leaving the European Union with a deal is the best exit outcome and has strongly expressed its opposition to leaving without a deal, in line with the position consistently expressed by Parliament. However, leaving without a deal on 31 October 2019 remains the legal default at the end of the Article 50 extension period if no withdrawal agreement is agreed. Therefore, as a responsible Government, we will continue to prepare to minimise any disruption to the supply of medicines and medical products in a ‘no deal’ scenario.</p><p> </p><p>The Department continues to work closely with the devolved administrations, relevant EU member states, industry trade bodies and suppliers, the National Health Service and our other main stakeholders to ensure that we are prepared for leaving the EU without a deal in October.</p><p>On 26 June, we wrote to suppliers of medicines to the United Kingdom from or via the EU or European Economic Area setting out our continuing multi-layered approach to ensure the continuity of supply of all medicines and medical products in a potential ‘no deal’ scenario on 31 October. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>We recognise that suppliers may incur additional storage costs for stockpiling medicines or switching to air freight We have been working closely with industry to minimise costs and support medicine suppliers taking part in the contingency programme.</p><p>The provision for additional warehouse space procured for a possible 29 March ‘no deal’ exit remains available for the 31 October deadline. The Department expects to spend around £11 million over the life of these contracts.</p><p> </p><p> </p><p> </p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 272242 272243 272245 272246 question first answered 10/07/2019 16:43:55 answering member 1585 label Biography information for Stephen Hammond
tabling member	4630 label Biography information for Ben Lake